Inventor
YANG ZHENFAN
CN12 patents
⚠️ This page may combine multiple inventors who share the name “YANG ZHENFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DIZAL JIANGSU PHARMACEUTICAL CO LTD
9 patentsUS10822334B2Nov 3, 2020
ErbB receptor inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD4 citations71
US11007198B2May 18, 2021
ErbB/BTK inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD2 citations68
US11896597B2Feb 13, 2024
ErbB/BTK inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations61
US11447492B2Sep 20, 2022
ERBB receptor inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations61
US11629147B2Apr 18, 2023
Triazolo-pyrimidine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations60
US11571420B2Feb 7, 2023
Pyrazine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations60
US10898481B2Jan 26, 2021
Pyrazine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations60
US10858365B2Dec 8, 2020
Triazolo-pyrimidine compounds and uses thereof
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations60
US11504375B2Nov 22, 2022
ErbB/BTK inhibitors
DIZAL JIANGSU PHARMACEUTICAL CO LTD1 citations58
ASTRAZENECA AB
3 patentsUS9375432B2Jun 28, 2016
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB1 citations60
US9066979B2Jun 30, 2015
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB3 citations60
US9718806B2Aug 1, 2017
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
ASTRAZENECA AB0 citations50